{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:46:16Z","timestamp":1789908376360,"version":"4.0.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.jinf.2018.04.001","type":"journal-article","created":{"date-parts":[[2018,5,6]],"date-time":"2018-05-06T09:45:15Z","timestamp":1525599915000},"page":"536-542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Real life efficacy of ledipasvir\/sofosbuvir in hepatitis C genotype 4\u2013infected patients with advanced liver fibrosis and decompensated cirrhosis"],"prefix":"10.1016","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3830-9236","authenticated-orcid":false,"given":"Faisal M.","family":"Sanai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim H.","family":"Altraif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Alswat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"AlZanbagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Babatin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdallah","family":"AlMousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawaf H","family":"Almutairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed S.","family":"Aljawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah S.","family":"Alghamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman A.","family":"Aljumah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abduljaleel M.","family":"Alalwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed K.","family":"Al-Hamoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah M.","family":"Assiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaser","family":"Dahlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwaq","family":"Alsahafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hammad S.","family":"Alothmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed S.","family":"AlSaleemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed A.","family":"Mousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Albenmousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelrahman","family":"Awny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haziz","family":"Albiladi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman A.","family":"Abdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamdan","family":"AlGhamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jinf.2018.04.001_bib0001","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.26141","article-title":"Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence","volume":"57","author":"Mohd Hanafiah","year":"2013","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jinf.2018.04.001_bib0002","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/MOG.0b013e3283457d5d","article-title":"Adult liver transplantation in the USA","volume":"27","author":"Alqahtani","year":"2011","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.jinf.2018.04.001_bib0003","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/hep.27259","article-title":"Global distribution and prevalence of hepatitis C virus genotypes","volume":"61","author":"Messina","year":"2015","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jinf.2018.04.001_bib0004","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","article-title":"Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study","volume":"2","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"Suppl","key":"10.1016\/j.jinf.2018.04.001_bib0005","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.4103\/1319-3767.188067","article-title":"SASLT guidelines: update in treatment of hepatitis C virus infection","volume":"22","author":"Alghamdi","year":"2016","journal-title":"Saudi J Gastroenterol"},{"issue":"5","key":"10.1016\/j.jinf.2018.04.001_bib0006","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/MCG.0000000000000896","article-title":"Efficacy and safety of simeprevir or daclatasvir in combination with sofosbuvir for the treatment of hepatitis c genotype 4 infection","volume":"52","author":"Babatin","year":"2018","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.jinf.2018.04.001_bib0007","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s12072-016-9749-y","article-title":"Interferon-free treatment for HCV-infected patients with decompensated cirrhosis","volume":"11","author":"Kanda","year":"2017","journal-title":"Hepatol Int"},{"issue":"4","key":"10.1016\/j.jinf.2018.04.001_bib0008","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/hep.28706","article-title":"Ledipasvir plus sofosbuvir for 12 weeks in patients with hepatitis C genotype 4 infection","volume":"64","author":"Abergel","year":"2016","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.jinf.2018.04.001_bib0009","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S1473-3099(15)00157-7","article-title":"Ledipasvir and sofosbuvir for hepatitis C genotype 4: a proof-of-concept, single-centre, open-label phase 2a cohort study","volume":"15","author":"Kohli","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"10.1016\/j.jinf.2018.04.001_bib0010","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(16)00052-9","article-title":"SOLAR-2 investigators. Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial","volume":"16","author":"Manns","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2018.04.001_bib0011","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jhep.2016.04.006","article-title":"Clinical value of on-treatment HCV RNA levels during different sofosbuvir-based antiviral regimens","volume":"65","author":"Maasoumy","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jinf.2018.04.001_bib0012","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1093\/cid\/civ170","article-title":"Utility of hepatitis C viral load monitoring on direct-acting antiviral therapy","volume":"60","author":"Sidharthan","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2018.04.001_bib0013","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(14)61228-9","article-title":"Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study","volume":"385","author":"Kohli","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jinf.2018.04.001_bib0014","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jhep.2016.09.001","article-title":"EASL recommendations on treatment of hepatitis C 2016","volume":"66","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jinf.2018.04.001_bib0015","unstructured":"AASLD\/IDSA HCV Guidance Panel. Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C. Available at www.hcvguidelines.org 2017 [last accessed on 2 May 2017]."},{"key":"10.1016\/j.jinf.2018.04.001_bib0016","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2147\/IDR.S153060","article-title":"Efficacy and safety of sofosbuvir-ledipasvir for treatment of a cohort of Egyptian patients with genotype 4 infection","volume":"11","author":"Ahmed","year":"2018","journal-title":"Infect Drug Resist"},{"issue":"4","key":"10.1016\/j.jinf.2018.04.001_bib0017","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1473-3099(15)70050-2","article-title":"Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS)","volume":"15","author":"Bourli\u00e8re","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.jinf.2018.04.001_bib0018","first-page":"436A","article-title":"Ledipasvir\/sofosbuvir in Egyptian patients with chronic genotype 4 HCV infection","volume":"64","author":"Shiha","year":"2016","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jinf.2018.04.001_bib0019","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.cgh.2017.02.020","article-title":"Spanish group for the study of the use of direct-acting drugs hepatitis c collaborating group. Real-world effectiveness and safety of oral combination antiviral therapy for hepatitis c virus genotype 4 infection","volume":"15","author":"Crespo","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jinf.2018.04.001_bib0020","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1056\/NEJMoa1402454","article-title":"Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection","volume":"370","author":"Afdhal","year":"2014","journal-title":"N Engl J Med"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016344531830104X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016344531830104X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:25:43Z","timestamp":1759008343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016344531830104X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S016344531830104X"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2018.04.001","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real life efficacy of ledipasvir\/sofosbuvir in hepatitis C genotype 4\u2013infected patients with advanced liver fibrosis and decompensated cirrhosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2018.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}